Evidence map›Paper›PMID 40066350›Full record

ArticleFrontiers in cardiovascular medicine2025

Association between estimated glucose disposal rate and incident cardiovascular disease in a population with Cardiovascular-Kidney-Metabolic syndrome stages 0-3: insights from CHARLS.

Ziyi Tan, Dayong Zhou, Yao Tang, Guijun Huo

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ziyi Tan *The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Dayong Zhou *The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Yao Tang *The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Guijun HuoThe Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Estimated glucose disposal rate (eGDR) is a reliable marker of insulin resistance (IR), which has been proven to be strongly linked to cardiovascular and renal diseases. However, the link between eGDR and the occurrence of cardiovascular disease (CVD) in individuals exhibiting Cardiovascular-Kidney-Metabolic (CKM) syndrome stages 0-3 remains ambiguous. Methods: The data employed in this investigation was procured from the China Health and Retirement Longitudinal Study (CHARLS). The outcome of this study was CVD events, which include heart disease and stroke. Cox regression models and restricted cubic spline (RCS) were employed to investigate the association between eGDR and CVD risk among individuals with CKM syndrome stages 0-3. Results: This investigation encompassed 6,539 subjects, and 54.43% were female. 1,656 (26.04%) CVD events were recorded. After fully adjusting for covariates, each 1-unit increase in eGDR was linked to a 9% diminish in CVD risk (HR: 0.91, 95% CI: 0.88, 0.93). In comparison to the bottom quartile of eGDR, the adjusted HRs (95% CIs) for the second to fourth quartiles were 0.73 (95% CI: 0.64, 0.83), 0.65 (95% CI: 0.56, 0.76), and 0.56 (95% CI: 0.47, 0.66), respectively. The RCS curves revealed a substantial negative nonlinear association between eGDR and CVD events among participants with CKM syndrome stages 0-3 ( Conclusions: In a population with CKM stages 0-3, a significant negative nonlinear relationship was observed between eGDR and CVD risk, suggesting that eGDR might function as a useful metric for evaluating CVD risk.

Indexed as

cardiovascular diseasesCardiovascular-Kidney-Metabolic syndromeCHARLSestimated glucose disposal rateinsulin resistance

Identifiers

PMID40066350
PMCPMC11891229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.